by Peter Ciszewski | May 17, 2021
Louise Vetter, President and CEO of the Huntington’s Disease Society of America, explains how all healthcare professionals, not just those specializing in Huntington disease, can help people with this rare condition. Huntington disease is an inherited,...
by Peter Ciszewski | May 13, 2021
Matthew Klein, MD, Chief Development Officer at PTC Therapeutics, explains the significance of risdiplam (evrysdi), a daily therapy for spinal muscular atrophy (SMA), being an oral treatment that can be self-administered. SMA is a rare inherited neuromuscular...
by Peter Ciszewski | May 12, 2021
Lauren Pinter-Brown, MD, Clinical Professor of Hematology/Oncology, University of California Irvine and Director of the Cutaneous Lymphoma Foundation, gives an overview of cutaneous T-cell lymphoma (CTCL) and how it is treated. CTCL belongs to the non-Hodgkin...
by Peter Ciszewski | May 11, 2021
Michael Levy, MD, PhD, Research Director of the Division of Neuroimmunology & Neuroinfectious Disease at Massachusetts General Hospital and Associate Professor in Neurology at Harvard Medical School, discusses the results of a study assessing attitudes of...
by Peter Ciszewski | May 7, 2021
Stanley Crooke, MD, PhD, Founder, Chairman, and Chief Executive Officer of Ionis Pharmaceuticals, discusses the n-Lorem Foundation, the nonprofit organization he founded. The n-Lorem Foundation is a charitable foundation focused on bringing treatment to...
